Picture of PhaseBio Pharmaceuticals logo

PHASQ — PhaseBio Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

U.S. STOCKS ON THE MOVE-Tesla, Amazon, Tapestry, Qiagen

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh


    The S&P 500 and Nasdaq indexes hit fresh record highs on Thursday on
optimism over an imminent U.S.-China trade deal that has put the benchmark index
on track for its best year since 2013.  .N 
    At 10:12 ET, the Dow Jones Industrial Average  .DJI  was up 0.14% at
28,554.04. The S&P 500  .SPX  was up 0.25% at 3,231.28 and the Nasdaq Composite
 .IXIC  was up 0.37% at 8,985.862.
 
 The top three S&P 500  .PG.INX  percentage gainers:
 ** Amazon.com Inc  AMZN.O , up 1.9%
 ** Capri Holdings Ltd  CPRI.N , up 1.5%
 ** Tapestry Inc  TPR.N , up 1.4%
 
 The top three S&P 500  .PL.INX  percentage losers:
 ** Advance Auto Parts Inc  AAP.N , down 1%
 ** Carmax Inc  KMX.N , down 0.9%
 ** Leggett & Platt Inc  LEG.N , down 0.9%
 
 The top three NYSE  .PG.N  percentage gainers:
 ** China Rapid Finance Ltd  XRF.N , up 126.2 %
 ** Rite Aid Corp  RAD.N , up 13 %
 ** Can Fite Biofarma Ltd  CANF.N , up 10.9 %
 
 The top two NYSE  .PL.N  percentage losers:
 ** Qiagen N V  QGEN.N , down 24.8 %
 ** Laix Inc  LAIX.N , down 7.6 %
 
 The top three Nasdaq  .PG.O  percentage gainers:
 ** Liquidia Technologies Inc  LQDA.O , up 79.8 %
 ** Newlink Genetics  NLNK.O , up 45.5 %
 ** Acorda Therapeutics Inc  ACOR.O , up 33.6 %
 
 The top three Nasdaq  .PL.O  percentage losers:
 ** Spectrum Pharmaceuticals Inc  SPPI.O , down 54 %
 ** Phasebio Pharmaceuticals Inc  PHAS.O , down 11.6 %
 ** Monopar Therapeutics Inc  MNPR.O , down 11.7 %
 
 
 
 ** Spring Bank Pharmaceuticals Inc  SBPH.O : down 49.1%
 BUZZ-Spring Bank Pharma: Down after co stops trial of drug for hepatitis B
virus  urn:newsml:reuters.com:*:nL4N2901E3
 
 ** Microbot Medical  MBOT.O : down 11.9%
 BUZZ-Microbot Medical: Plunges on discounted stock offer to raise funds for
robot development  urn:newsml:reuters.com:*:nL4N2901F1
 
 ** Spectrum Pharmaceuticals Inc  SPPI.O : down 54.0%
 BUZZ-Spectrum Pharma plunges after cancer drug fails mid-stage trial
 urn:newsml:reuters.com:*:nL4N2901H9
 
 ** Acasti Pharma Inc  ACST.O : up 9.8%
  BUZZ-Acasti Pharma: Data delay provides opportunity for investors- Oppenheimer
 urn:newsml:reuters.com:*:nL4N2901IN
 
 ** Tesla Inc  TSLA.O : up 0.9%
 BUZZ-Tesla: Wedbush raises PT by $100, says co to "comfortably" meet FY
delivery forecast  urn:newsml:reuters.com:*:nL4N2901F3
 
 ** Qiagen NV  QGEN.N : down 24.8%
 BUZZ-Qiagen: Plunges after co decides against sale  urn:newsml:reuters.com:*:nL4N2901J4
 
 ** Hexo Corp  HEXO.N : down 18.9%
 BUZZ-Hexo Corp: Falls on deal to sell shares at discount to institutional
investors  urn:newsml:reuters.com:*:nL4N2901K2
 
 ** China Rapid Finance  XRF.N : up 126.2%
 BUZZ-China Rapid Finance jumps on $8 mln investment  urn:newsml:reuters.com:*:nL4N2901LQ
 
 ** Digital Ally Inc  DGLY.O : up 2.4%
 BUZZ-Digital Ally: Rises on partnership with Pivot to develop breathalyzer
 urn:newsml:reuters.com:*:nL4N2901M0
 
 ** Amazon.com Inc  AMZN.O : up 1.9%
 BUZZ-Amazon hits 1-month high as online sales drive U.S. holiday shopping
 urn:newsml:reuters.com:*:nL4N2901NW
    
    
 The 11 major S&P 500 sectors:
 
 Communication Services   .SPLRCL   up 0.29%
 Consumer Discretionary   .SPLRCD   up 0.50%
 Consumer Staples         .SPLRCS   up 0.27%
 Energy                   .SPNY     up 0.32%
 Financial                .SPSY     up 0.25%
 Health                   .SPXHC    up 0.11%
 Industrial               .SPLRCI   down 0.09%
 Information Technology   .SPLRCT   up 0.38%
 Materials                .SPLRCM   down 0.03%
 Real Estate              .SPLRCR   up 0.18%
 Utilities                .SPLRCU   up 0.08%
 
 (Compiled by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91
80 6749 7786;))

Recent news on PhaseBio Pharmaceuticals

See all news